Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NXL103 vs Linezolid in ABSSSI
NCT00949130Phase 2Completed
- Sponsor
- Novexel
- Start
- Nov 2009
- Primary completion
- Mar 2010
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of flopristin + linopristin in acute bacterial skin and skin structure infection (ABSSSI), sponsored by Novexel. Started Nov 2009; status: completed.
02
Drugs
flopristin + linopristin
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT00949130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949130.